BioSpace Unveils Its First 40 Under 40 Class of Trailblazers in Biotech

BioSpace's Inaugural 40 Under 40 Winners Revealed

On October 7, 2025, BioSpace, a prominent player in biopharma news and careers, announced its first-ever 40 Under 40 list, recognizing exceptional young talent in the biopharmaceutical industry. This initiative aims to honor individuals who have made significant contributions to their companies and the broader field, showcasing the vibrancy and innovation of the biotech sector.

The 40 Under 40 accolade is not just a title; it represents the vision, creativity, and impactful work done by young professionals who are shaping the future of healthcare. Commenting on the awards, Josh Goodwin, CEO of BioSpace, stated, "These individuals demonstrate why the biopharma industry will continue to persevere—determination to improve health through innovation, creativity and leading with conviction.” His words encapsulate the essence of what these honorees bring to the table: a relentless pursuit of better healthcare solutions through innovation.

This year's winners span various therapeutic areas and functional roles within their respective organizations. Here are some of the outstanding leaders making waves in the industry:

1. Tetiana Aleksandrova - CEO and Co-Founder of Subsense
2. Kristen Anderson - Associate General Counsel at Verona Pharma
3. Nkiru Anyagaligbo - Digital Lead for Rare Conditions at Apellis
4. Andrew Barnhill - Head of Public Policy and Government Affairs at IQVIA
5. Daniel Barvin - VP of Operations and Patient Advocacy at Coya Therapeutics
6. Neena Bitritto-Garg - Founder and CEO of Ensho Therapeutics
7. Francesco Borriello - Executive Director at GenerateBiomedicines
8. Shelley Brathwaite - Director of Patient Marketing Oncology at Sumitomo Pharma America
9. Lena Ceballos - Corporate Communications and Marketing Manager at Arcturus Therapeutics
10. Alexandra Collin de l'Hortet - VP of Therapeutics at Epicrispr Biotechnologies

The list continues with remarkable individuals from various organizations that are committed to making a difference in healthcare. Each leader embodies the qualities that drive the industry forward: innovation, a clear vision, and an unwavering commitment to patient outcomes.

Nominations for the 40 Under 40 were open from May to August, and to qualify, nominees had to be U.S.-based, aged 39 or under, and hold leadership roles in biotech or pharma companies. This openness encouraged a diverse range of nominees across disciplines, showcasing the extensive talent present in the industry.

BioSpace functions as a vital hub for life sciences, connecting innovative organizations with talented professionals dedicated to advancing healthcare and improving quality of life globally. With initiatives like the 40 Under 40, BioSpace not only honors current leaders but also inspires the next generation of innovators in the biopharma landscape.

As these young leaders forge ahead in their careers, they set a powerful precedent for future generations in the biotech and pharma sectors. Their stories of success and determination serve as beacons of hope that illustrate how passion and innovation can lead to significant advancements in health and patient care.

By featuring such exceptional talent, BioSpace emphasizes the importance of recognizing and uplifting young professionals who are playing critical roles in healthcare's evolution. The inaugural 40 Under 40 list is expected to become a prestigious recognition that many in the industry will strive to achieve, reinforcing the notion that the future of biopharma is indeed bright and full of promise.